Inhaled Therapy - for further information, see LTHT Nebuliser Guidelines for Adults or Children

Size: px
Start display at page:

Download "Inhaled Therapy - for further information, see LTHT Nebuliser Guidelines for Adults or Children"

Transcription

1 Inhaled Therapy - for further information, see LTHT Nebuliser Guidelines for Adults or Children Link to: Adult Nebuliser Guidelines Link to: Paediatric Nebuliser Guidelines and Monographs ANTIBIOTICS/ ANTIFUNGALS Dose Notes Amikacin Amphoteracin (AmBisome ) Aztreonam lysine Colistimethate sodium(colistin) Colomycin Colistimethate sodium(colistin) Promixin Inhaled colistimethate sodium Colobreathe capsules for inhalation Meropenem <12years: 250mg twice daily >12years: 500mg twice daily 25mg twice daily for 7-10 days, although longer courses have been used in adults. Over 6years: 75mg three times a day Under 2 years: 1 million units twice daily Over 2 years: 2 million units twice daily 1million units twice daily Adults and children over 6 years: 1.66 million units twice daily 6-11years: 125mg twice daily 12years+ : 250mg twice daily Use injection (250mg/mL) and make up to 4 mls with sodium chloride 0.9%. Dissolve 50mg vial with 12mLs sterile water. Nebulise with a CR50, CR60 or Turboneb compressor. Monitor for bronchospasm. Supplied with diluent. Using conventional nebulisers: 1 million units: reconstitute with 4 mls sodium chloride 0.9%. 2 million units: reconstitute with 2 mls WFI and 2 mls sodium chloride 0.9% Seek advice for use with other nebulisers. Using the I-neb -The 1 million units (1,000,000) vial is reconstituted with 1mL water for injection and administered TWICE daily. Requires verbal Microbiology approval. Make to 5mLs with water for injection.

2 Tobramycin Tobi 300mg in 5mL Bramitob 300mg in 4mL Tobramycin powder for inhalation Tobi Podhaler Vancomycin MUCOLYTICS Dornase alfa (Pulmozyme ) Mannitol (Bronchitol ) Sodium chloride 7% ( Nebusal ), 3% Mucoclear 6months-6years (unlicensed): 300mg twice daily, alternate months. >6 years: 300mg twice daily, alternate months. Although only licensed in children over 6 years, this dose is used in children of all ages over 6 months Adult and child over 6 years: 112mg (4 x 28mg capsules) every 12 hours for 28 days, subsequent courses repeated after 28-day interval without tobramycin inhalation powder Child: 5mg/kg (max: 250mg) twice daily 250mg twice daily For five days usually. 2.5mg (2500units) daily Adult 18yrs and above; 400mg twice daily (Ten 40mg capsules twice a day). 4mLs up to twice a day, before physiotherapy Ready for use solutions. No further dilution necessary. NTM in Cystic Fibrosis Some patients may be on continuous tobramycin or alternate it with another inhaled antibiotic. Prescriptions should clearly state whether it is alternate months or continuous. NTM in Cystic Fibrosis Some patients may be on continuous tobramycin or alternate it with another inhaled antibiotic. Prescriptions should clearly state whether it is alternate months or continuous. Use water for injection for reconstitution and make up to 4mLs with water for injection. i.e. for 250mg dose reconstitute a 500mg vial with 8mLs water for infection and use 4mL. Administer a bronchodilator beforehand, to minimise bronchospasm. Licensed for children over 5 years of age. Limited patients may benefit from twice daily administration. Patient needs to complete test dose regimen prior to starting. 3% used when patient is unable to tolerate 7%. OTHER Taurolidine solution 2% (Taurolin ) Adults: 3-4mLs of 2% solution twice daily Unlicensed product, available as an intraperitoneal lavage (Taurolin ) on a named patient basis. May cause bronchospasm, cough or mild burning sensation in the throat.

3 Give a test dose initially. Gastrointestinal and Liver Disease DRUG DOSE NOTES N-acetylcysteine 200mg/mL injection, Parvolex, given orally Sachets of granules 200mg (Fluimicil N, unlicensed) Treatment of DIOS Child 1 month - 2 years Child 2-7 years Child 7 years- adult Prevention of DIOS Child 1 month - 2 years Child 2-12 years Child 12 years - adult 0.4g (2mL)-3g(15mLs) as a single dose 2g (10mL)-3g (15mLs) as a single dose 4g (20mLs)-6g (30mLs) as a single dose mg three times a day 200 mg three times a day mg three times a day 400mg three times a day Erythromycin (for gastric stasis only) All ages 3 mg/kg (20 minutes before feeds) four times a day. Max: 250 mg four times a day Dilute injection to a concentration of 50mg/mL; orange or blackcurrant juice or cola drink may be used as a diluent to mask the bitter taste. Single dose may be repeated up to three times a day. Acetylcysteine 20%, 30mLs, can also be added to a phosphate enema and given rectally for DIOS. Oral Gastrografin DAY 1: 1 month- 2 years kg ml diluted to mL with water or cordial, once daily 50 ml diluted to 200mL with water or cordial, once daily Hydration of patient is essential, monitor intravascular fluid volume carefully. Fluid intake should be encouraged for 3 hours after administration. Over 25 kg 100 ml with 400 ml of water or cordial once daily DAY 2 & 3 Half Day 1 dose Rectal Gastrografin 1 month- 2 years 2-12 yrs, <25 kg ml single dose 50 ml single dose Dilute enema 3-5 times with water. Administer under radiological

4 Over 25 kg 100 ml single dose guidance only. Klean Prep orally or via nasogastric tube Children: 10 ml/kg/hr for 30 mins then 20 ml/kg/hr for 30 mins then increase to 25 ml/kg/hr if well tolerated. Max volume over 4 hours: 100 mls/kg or 4L, whichever is smaller. Patients must be reviewed at 4 hours. If output is not yet clean, a further 4 hours treatment may be prescribed. Max total volume over 8 hours: 200 ml/kg or 8L, whichever is smaller. In practice we seldom administer more than 4L in any 24 hour period, and more usually prescribe 2L a day for 2 days. Adults: 1 sachet in one litre water, twice a day Hypoglycaemia has been reported. Lansoprazole Orodispersible tablets or capsules Infant 2.5kg-5kg 5-10kg 10-30kg >30kg 3.75mg (¼ a 15mg tablet) once daily 7.5mg (½ a 15mg tablet)once daily 15mg once daily 30mg once daily Movicol Child: 1-5 years 2 sachets on first day, then 4 sachets daily for 2 days, then 6 daily for 2 days, then 8 sachets daily for 2 days. Treat until impaction resolves or for max of 7 days. Total daily dose to be taken over 12 hour period. For impaction 5-12 years 4 sachets on first day then increased in steps of 2 sachets daily to max 12 sachets daily. After disimpaction, switch to maintenance laxative therapy. See BNF/BNFc years and adults: Movicol 2 sachets twice daily increasing to 8 sachets /day. Total daily dose to be drunk within six hour period (BNF). Omeprazole capsules or MUPS (dispersible tablets) 1 month 2 years 10-20kg 20kg+ and adults 0.7mg/kg 3mg/kg daily(max 20mg/day) 10-20mg daily 20-40mg daily Total daily dose may be divided into two daily doses if required Swallow capsules whole or open and mix contents with fruit juice or yoghurt. MUPS tablets can be dissolved in water. Consider lansoprazole orodispersible tablets as an alternative for children, and disperse in water. Ranitidine Under 6 months 1 mg/kg three times a day (Max 9 In fat malabsorption, give 1-2hours

5 6 months 18 years mg/kg/day) 2 4 mg/kg (Max. 300 mg) twice daily before food to enhance effects of enzyme replacements. Ursodeoxycholic acid 150mg tabs, 250mg caps, suspension 50mg/mL 1month-18years: 10-15mg/kg twice daily, or total daily dose divided into three doses. Usual max: 600mg three times a day. Max: 2750mg daily in divided doses. Take with or after food. SALT SUPPLEMENTATION Sodium chloride tablets. Slow Sodium 600 mg NaCl (10mmol Na+) Sodium chloride solution 1mmol/mL. In hot weather, fever or vigorous exercise. <2 years additional 2mmol/kg/day in divided doses 2-7years; 10-20mmol/day ( mg) in divided doses >7 years: 2-4g/day in divided doses 60-80mmol per day (3.6g-4.8g, 6 to 8 tablets) in divided doses The usual dose for adults with Cystic Fibrosis is 2 tablets three times a day of Slow Sodium (600mg) daily. These should be taken at regular intervals during the day, with plenty of water Slow Sodium cannot be crushed. Dioralyte sachets can be used in young children or babies. Encourage fluid intake.

DRUG: Introduction. `Shared Care Guidelines. They can also be used long term for chronic pulmonary Pseudomonas aeruginosa infection.

DRUG: Introduction. `Shared Care Guidelines. They can also be used long term for chronic pulmonary Pseudomonas aeruginosa infection. `Shared Care Guidelines DRUG: Introduction Inhaled antibiotics (Adults and Paediatrics) in Cystic Fibrosis. EXISTING ESTABLISHED PATIENTS ONLY Colistimethate (Colomycin, Promixin ) Tobramycin (Tobi Bramitob

More information

Adult Dose. Adults Day 1: 1mg/kg daily Day 2: 2mg/kg daily Day 3 onwards: 3mg/kg daily. Where appropriate consider rounding dose to nearest 50mg.

Adult Dose. Adults Day 1: 1mg/kg daily Day 2: 2mg/kg daily Day 3 onwards: 3mg/kg daily. Where appropriate consider rounding dose to nearest 50mg. AMIKACIN All ages>1month: 30mg/kg daily 1.5g once daily IV infusion over 30-60 Monitor renal function before treatment and weekly. Caution if used with other nephrotoxic drugs. Levels required. Trough

More information

LRI Children s Hospital

LRI Children s Hospital Title: Prescribing in Cystic Fibrosis Page 1 of 10 LRI Children s Hospital Prescribing in Cystic Fibrosis Staff relevant to: Clinical staff working within the UHL Children s Hospital. Team & AWP approval

More information

Nebulised mucolytic and antibiotic solutions for the treatment of Cystic Fibrosis in paediatric patients NOTES to the GP

Nebulised mucolytic and antibiotic solutions for the treatment of Cystic Fibrosis in paediatric patients NOTES to the GP SHARED CARE PRESCRIBING GUIDELINE Nebulised mucolytic and antibiotic solutions for the treatment of Cystic Fibrosis in existing paediatric patients only (i.e. those already being prescribed such drugs

More information

Appendix D Clinical specialist statement template

Appendix D Clinical specialist statement template Appendix D Colistimethate sodium powder and tobramycin powder for inhalation for the treatment of pseudomonas lung infection in cystic fibrosis Thank you for agreeing to give us a statement on your organisation

More information

Therapeutic options for adult patients unable to take solid oral dosage forms (Adapted from UKMi Q&A for use in Northern Ireland) Sep 2015

Therapeutic options for adult patients unable to take solid oral dosage forms (Adapted from UKMi Q&A for use in Northern Ireland) Sep 2015 Therapeutic options for adult patients unable to take solid oral dosage forms (Adapted from UKMi Q&A 294.3 for use in Northern Ireland) Sep 2015 BNF 1.3.5 Proton pump inhibitors Lansoprazole orodispersible

More information

PEDIATRIC CYSTIC FIBROSIS PLAN - Phase:.

PEDIATRIC CYSTIC FIBROSIS PLAN - Phase:. PHYSICIAN S Diagnosis Weight Allergies Patient Care Vital Signs Per Unit Standards Per Unit Standards, with Sleeping SpO2 nightly until sat greater than 92% Daily Weight Every AM In AM on Monday, Wednesday,

More information

BNF CHAPTER 1: GASTRO-INTESTINAL SYSTEM. 1 April 13

BNF CHAPTER 1: GASTRO-INTESTINAL SYSTEM. 1 April 13 BNF CHAPTER 1: GASTRO-INTESTINAL SYSTEM 1 BNF 1.1 ANTACIDS Mucogel and Peptac are effective antacids and are available over the counter Gaviscon / Gaviscon Advance are available over the counter First

More information

Package Leaflet: Information for the User

Package Leaflet: Information for the User Package Leaflet: Information for the User KLEAN-PREP 69g Sachet Powder for Oral Solution Macrogol 3350, Sodium sulphate anhydrous, Sodium bicarbonate, Sodium chloride and Potassium chloride Read all of

More information

IN USE PRODUCT SAFETY ASSESSMENT REPORT FOR COLISTIMETHATE SODIUM

IN USE PRODUCT SAFETY ASSESSMENT REPORT FOR COLISTIMETHATE SODIUM BACKGROUND IN USE PRODUCT SAFETY ASSESSMENT REPORT FOR COLISTIMETHATE SODIUM SUMMARY OF ASSESSMENT AND ITS FINDINGS Colistimethate sodium (colistin sulfomethate sodium) is licensed in the UK to be given

More information

REGISTRATION ASSESSMENT SITTINGS Part 1 example questions. 1. Questions 1 to 12 are examples from part 1 of the registration assessment.

REGISTRATION ASSESSMENT SITTINGS Part 1 example questions. 1. Questions 1 to 12 are examples from part 1 of the registration assessment. Notes REGISTRATION ASSESSMENT SITTINGS 2018 Part 1 example questions 1. Questions 1 to 12 are examples from part 1 of the registration assessment. 2. The answers are on page 14. 3. Unless specified, give

More information

Changes in the management of children with Cystic Fibrosis. Caroline Murphy & Deirdre O Donovan CF Nurses

Changes in the management of children with Cystic Fibrosis. Caroline Murphy & Deirdre O Donovan CF Nurses Changes in the management of children with Cystic Fibrosis Caroline Murphy & Deirdre O Donovan CF Nurses What Is Cystic Fibrosis? Cystic fibrosis (CF) is an inherited chronic disease that primarily affects

More information

DATA SHEET 2 QUALITATIVE AND QUANTITATIVE COMPOSITION

DATA SHEET 2 QUALITATIVE AND QUANTITATIVE COMPOSITION DATA SHEET 1 PRODUCT NAME 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Sachet, each 5.1g sachet contains: Sodium chloride 470mg, potassium chloride 300mg, sodium acid citrate 530mg, glucose 3.56g. Tablet,

More information

Prescribing Guidance for the Treatment of Constipation in Children

Prescribing Guidance for the Treatment of Constipation in Children Prescribing Guidance for the Treatment of Constipation in Children Effective Date: July 2007 Reviewed: September 2009 & December 2011 Review Date: December 2013 Gateshead Medicines Management Approved

More information

BNF CHAPTER 3: RESPIRATORY

BNF CHAPTER 3: RESPIRATORY 3.1 BRONCHODILATORS BNF CHAPTER 3: RESPIRATORY 3.1.1.1 SELECTIVE BETA 2 -AGONISTS Short acting Salbutamol 100 micrograms/actuation aerosol inhaler 100 micrograms/actuation breath-actuated (e.g., Easi-Breathe

More information

ASSESSMENT OF THE PAEDIATRIC NEEDS GASTRO-ENTEROLOGY DISCLAIMER

ASSESSMENT OF THE PAEDIATRIC NEEDS GASTRO-ENTEROLOGY DISCLAIMER European Medicines Agency Evaluation of Medicines for Human Use London, October 2007 Doc. Ref. EMEA/527934/2007 ASSESSMENT OF THE PAEDIATRIC NEEDS GASTRO-ENTEROLOGY DISCLAIMER The Paediatric Working Party

More information

July Formulary Policy

July Formulary Policy Formulary Policy July 2017 Responsible Committee: Quality Committee Date Effective: July 2017 Author: Rahinatu Amadu Supersedes: July 2016 Next Review Due: July 2018 Formulary Policy 2016-2018 1. INTRODUCTION

More information

Artesunate 60 mg for injection WHOPAR part 3 June 2013 (Guilin Pharmaceutical Co., Ltd.), MA051 PATIENT INFORMATION LEAFLET

Artesunate 60 mg for injection WHOPAR part 3 June 2013 (Guilin Pharmaceutical Co., Ltd.), MA051 PATIENT INFORMATION LEAFLET PATIENT INFORMATION LEAFLET 1 PATIENT INFORMATION LEAFLET: INFORMATION FOR THE USER Artesun * Artesunate 60 mg for injection and sodium bicarbonate injection 50 mg/ml (1ml) and sodium chloride injection

More information

Chapter 5 Gastroenterology. Dose. Route. Units. Given. Dose. Route. Units. Given

Chapter 5 Gastroenterology. Dose. Route. Units. Given. Dose. Route. Units. Given Chapter 5 Gastroenterology Georgia Woodfield TERLIPRESSIN CIPROFLOXACIN 2 initial dose 500 Every 4 hours until bleeding controlled can be reduced to 1 after initial dose if side effects develop or if patient

More information

Guidelines for the use of Nebulised Colistemethate Sodium (Colomycin) Injection () in Pseudomonas aeruginosa Lung Infections in Adults

Guidelines for the use of Nebulised Colistemethate Sodium (Colomycin) Injection () in Pseudomonas aeruginosa Lung Infections in Adults Index No: MMG41 Guidelines for the use of Nebulised Colistemethate Sodium (Colomycin) Injection () in Pseudomonas Version: 2 Date ratified: November 2017 Ratified by: (Name of Committee) Name of originator/author,

More information

Cystic Fibrosis: Pulmonary Exacerbations Management Guidelines

Cystic Fibrosis: Pulmonary Exacerbations Management Guidelines Cystic Fibrosis: Pulmonary Exacerbations Management Guidelines Inclusion Criteria: Age 1 year with cystic fibrosis admitted for a pulmonary exacerbation. Exclusion Criteria: ICU Admission Newborn with

More information

3 RESPIRATORY SYSTEM

3 RESPIRATORY SYSTEM 3 RESPIRATORY SYSTEM 3.01 ANTIASTHMATICS 3.01a BETA 2 AGONIST ASTHMA, CHRONIC BRONCHITIS & EMPHYSEMA Salbutamol Inhaler 100ug/dose [Albuterol] (Ventolin) Salbutamol Sulphate Respirator Solution 0.5% (5mg/ml),

More information

Medicines Q&As Q&A What are the therapeutic options for patients unable to take solid oral dosage forms?

Medicines Q&As Q&A What are the therapeutic options for patients unable to take solid oral dosage forms? Medicines Q&As Q&A 294.3 What are the therapeutic options for patients unable to take solid oral dosage forms? Prepared by UK Medicines Information (UKMi) pharmacists for NHS healthcare professionals Before

More information

Southern Trust Home IV Service. Guidelines for the administration of IV antibiotics

Southern Trust Home IV Service. Guidelines for the administration of IV antibiotics Southern Trust Home IV Service Guidelines for the administration of IV antibiotics Title: Author: CLINICAL GUIDELINES ID TAG Antibiotic guidelines - Southern Trust Home IV service guidelines for the administration

More information

Primary Care Constipation Guidelines. Version 1 November 2016

Primary Care Constipation Guidelines. Version 1 November 2016 Primary Care Constipation Guidelines Version 1 November 2016 VERSION CONTROL Version Date Amendments made Version 1 November 2016 New guideline Contents 1. Management of constipation in adults: acute and

More information

NEWBORN EMERGENCY TRANSPORT SERVICE MEDICAL GUIDELINES

NEWBORN EMERGENCY TRANSPORT SERVICE MEDICAL GUIDELINES WOMEN AND NEWBORN HEALTH SERVICE King Edward Memorial Hospital NEWBORN EMERGENCY TRANSPORT SERVICE MEDICAL GUIDELINES Transport Medication List Title of policy: Transport Medication List Date Revised:

More information

Contents. Who should read / have access to this document? What is new in this version?

Contents. Who should read / have access to this document? What is new in this version? 1 Nebulised Colistin Colistimethate sodium (Colomycin ) for the treatment of Pseudomonas Aeruginosa colonisation and infection in adult patients with non-cystic Fibrosis bronchiectasis or bronchial sepsis

More information

GASTRO-INTESTINAL SYSTEM 1.1 Dyspepsia and gastro-oesophageal reflux disease

GASTRO-INTESTINAL SYSTEM 1.1 Dyspepsia and gastro-oesophageal reflux disease Original Date of issue: 05/04/07 Last eviewed: 08/03/2013 Version: 5 Page 1 of 11 GASTO-INTESTINAL SYSTEM 1.1 Dyspepsia and gastro-oesophageal reflux disease 1.1.1 Antacids and simeticone Magnesium Trisilicate

More information

Cumulative Math Practice Worksheet

Cumulative Math Practice Worksheet Name: Date: Use the following to answer questions 1-3: Fill in the blank for each pair of ratios to form a proportion: 1. How many capsules are needed to fill a prescription for three days for mefenamic

More information

Dehydration and Oral Rehydration Solutions

Dehydration and Oral Rehydration Solutions Health Professional Training Guide Up to 75% less sugar and 4x more electrolytes vs. the leading sports drinks Wide range of innovate formats and great tasting flavors Lasts for 30 days in the refrigerator

More information

Artesunate 60 mg for injection WHOPAR part 3 November 2015 (Guilin Pharmaceutical Co., Ltd.), MA051 PATIENT INFORMATION LEAFLET

Artesunate 60 mg for injection WHOPAR part 3 November 2015 (Guilin Pharmaceutical Co., Ltd.), MA051 PATIENT INFORMATION LEAFLET PATIENT INFORMATION LEAFLET 1 PATIENT INFORMATION LEAFLET: INFORMATION FOR THE USER Artesun 60mg * Artesunate 60 mg for injection and sodium bicarbonate injection 50 mg/ml (1ml) and sodium chloride injection

More information

Children & Young People s Directorate Paediatric-Neonatal Guidelines Checklist & Version Control Sheet

Children & Young People s Directorate Paediatric-Neonatal Guidelines Checklist & Version Control Sheet 1 Children & Young People s Directorate Paediatric-Neonatal Guidelines Checklist & Version Control Sheet 1 Name of Guideline / Policy/ Procedure MANAGEMENT OF ACUTE PAEDIATRIC ASTHMA Purpose of Procedure/

More information

500 micrograms/dose Turbohaler dry powder device 500 micrograms/ml injection. 12 micrograms/dose Turbohaler dry powder device

500 micrograms/dose Turbohaler dry powder device 500 micrograms/ml injection. 12 micrograms/dose Turbohaler dry powder device 3.1 BRONCHODILATORS 3.1.1.1 SELECTIVE BETA 2 -AGONISTS Short acting Salbutamol Terbutaline 100 micrograms/actuation aerosol inhaler 100 micrograms/actuation breath-actuated e.g. Easi-Breathe 200 micrograms/dose

More information

Alternative Routes of Administration

Alternative Routes of Administration Alternative Routes of Administration When PO is NOT an Option Presented by: Zachary T. Hopkins, PharmD Outline Medication Delivery Routes and Necessity Inhaled Antibiotics for Cystic Fibrosis New Inhaled

More information

Nebulised (inhaled) Colistin (Colomycin )

Nebulised (inhaled) Colistin (Colomycin ) Newcastle Bronchiectasis Service Cardiothoracic Directorate Nebulised (inhaled) Colistin (Colomycin ) Your doctor has prescribed a drug called Colistin (or Colomycin ) for you. This is an inhaled drug,

More information

A patient s guide to the. management of constipation following surgery

A patient s guide to the. management of constipation following surgery A patient s guide to the management of constipation following surgery This leaflet has been designed to give you more information about using laxatives after your surgery. What is constipation? After your

More information

Dietetic Management of Infants Diagnosed With Cystic Fibrosis

Dietetic Management of Infants Diagnosed With Cystic Fibrosis Scottish Paediatric Cystic Fibrosis MCN Dietetic Management of Infants Diagnosed With Cystic Fibrosis Prepared by: Scottish CF Paediatric Dietitians Group Lead Author: Julie Crocker, Royal Hospital for

More information

UNIVERSITY OF BOLTON SCHOOL OF HEALTH AND HUMAN SCIENCES BSC (HONS) PRE-REGISTRATION NURSING EDUCATION (ADULT) SEMESTER ONE EXAMINATION 2016/17

UNIVERSITY OF BOLTON SCHOOL OF HEALTH AND HUMAN SCIENCES BSC (HONS) PRE-REGISTRATION NURSING EDUCATION (ADULT) SEMESTER ONE EXAMINATION 2016/17 LJW3 UNIVERSITY OF BOLTON SCHOOL OF HEALTH AND HUMAN SCIENCES BSC (HONS) PRE-REGISTRATION NURSING EDUCATION (ADULT) SEMESTER ONE EXAMINATION 2016/17 FOUNDATIONS OF MEDICINES MANAGEMENT MODULE CODE: HLT4085

More information

BNF CHAPTER 1: GASTRO-INTESTINAL SYSTEM

BNF CHAPTER 1: GASTRO-INTESTINAL SYSTEM BNF CHAPTER 1: GASTRO-INTESTINAL SYSTEM 1 ANTACIDS Maalox and Peptac are effective antacids that can be bought Over the Counter for self-limiting symptoms. Choice Product Cost Effective Options &Comments

More information

Admission of a Child/Young Person with Cystic Fibrosis Clinical Guideline V3.0 May 2018

Admission of a Child/Young Person with Cystic Fibrosis Clinical Guideline V3.0 May 2018 Admission of a Child/Young Person with Cystic Fibrosis Clinical Guideline V3.0 May 2018 Page 1 of 16 1. Aim/Purpose of this Guideline This guideline applies to all staff caring for children/young people

More information

Opinion 18 December TADIM 1 million international units (IU) of powder for nebuliser solution Box30 vials (CIP: )

Opinion 18 December TADIM 1 million international units (IU) of powder for nebuliser solution Box30 vials (CIP: ) The legally binding text is the original French version TRANSPARENCY COMMITTEE Opinion 18 December 2013 TADIM 1 million international units (IU) of powder for nebuliser solution Box30 vials (CIP: 34009

More information

Cystic Fibrosis Antibiotic Guidelines

Cystic Fibrosis Antibiotic Guidelines Cystic Fibrosis Antibiotic Guidelines Title of Guideline (must include the word Guideline (not protocol, policy, procedure etc) Contact Name and Job Title (author) Directorate & Speciality Date of submission

More information

Colistimethate sodium for injection and inhalation COLISTIN COMPOSITION

Colistimethate sodium for injection and inhalation COLISTIN COMPOSITION Colistin, Colistimethate sodium, injection, cyclic polypeptide antibiotic, manufacturers, India, infusion, inhalation, Taj Products Pharmaceuticals, Allopathic Products Manufacturer,exporter,Supplier,india,formulations,medicines,injections,insulin,free

More information

Citation for published version (APA): Westerman, E. M. (2009). Studies on antibiotic aerosols for inhalation in cystic fibrosis s.n.

Citation for published version (APA): Westerman, E. M. (2009). Studies on antibiotic aerosols for inhalation in cystic fibrosis s.n. University of Groningen Studies on antibiotic aerosols for inhalation in cystic fibrosis Westerman, Elisabeth Mechteld IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF)

More information

UNIVERSITY OF BOLTON SCHOOL OF HEALTH AND HUMAN SCIENCES BSC (HONS) PRE-REGISTRATION NURSING EDUCATION (ADULT) SEMESTER ONE EXAMINATION 2015/2016

UNIVERSITY OF BOLTON SCHOOL OF HEALTH AND HUMAN SCIENCES BSC (HONS) PRE-REGISTRATION NURSING EDUCATION (ADULT) SEMESTER ONE EXAMINATION 2015/2016 ljs7 UNIVERSITY OF BOLTON SCHOOL OF HEALTH AND HUMAN SCIENCES BSC (HONS) PRE-REGISTRATION NURSING EDUCATION (ADULT) SEMESTER ONE EXAMINATION 2015/2016 FOUNDATIONS OF MEDICINES MANAGEMENT MODULE CODE: HLT4085

More information

BNF 9: Blood and Nutrition

BNF 9: Blood and Nutrition FORMULARY CHOICE RESTRICTED 1 Blood and Blood-Forming Organs 1.1 Anaemias Epoetins Epoetinalfa pre-filled (Eprex ) 1,000unit 2,000unit 3,000unit 4,000unit 5,000unit 6,000unit 8,000unit 10,000unit 20,000unit

More information

Hypertonic Saline (7%) Administration Guideline (adults)

Hypertonic Saline (7%) Administration Guideline (adults) Hypertonic Saline (7%) Administration Guideline (adults) Full Title of Guideline: Author (include email and role): Hypertonic Saline (7%) Administration Guideline for Practice (Adults) Clair Martin, Senior

More information

Pseudomonas aeruginosa eradication guideline

Pseudomonas aeruginosa eradication guideline SCOTTISH PAEDIATRIC CYSTIC FIBROSIS MCN Pseudomonas aeruginosa eradication guideline Date Created: 27 th June 2013 Date Approved by Steering Group: 30 th May 2014 Date of Review: 31 st May 2016 Lead Author:

More information

Operational Guide for School Oral Health Program. Prescribing Medicine

Operational Guide for School Oral Health Program. Prescribing Medicine Prescribing Clinical Protocols Medicine Operational Guide for School Oral Health Program Prescribing Medicine 107 Prescribing Medicine 43, 44, 45 The Kuwait drug index is the only authoritative source

More information

Module 8: Practice Problems

Module 8: Practice Problems Module 8: Practice Problems 1. Convert a blood plasma level range of 5 to 20 µg/ml of tobramycin (Z = 467.52) to µmol/l. 5 µg/ml = 10.7 µmol/l 20 µg/ml = 42.8 µmol/l 2. A preparation contains in each milliliter,

More information

Mucomist Respirator Solution, Acetylcysteine USP 200 mg/ ml Solution for inhalation (not for injection)

Mucomist Respirator Solution, Acetylcysteine USP 200 mg/ ml Solution for inhalation (not for injection) Mucomist Respirator Solution, Acetylcysteine USP 200 mg/ ml Solution for inhalation (not for injection) DESCRIPTION Mucomist Respirator Solution is a derivative of the amino acid, cysteine. It acts mostly

More information

Package leaflet: Information for the patient AMIKIN INJECTION 100 mg/2ml Amikacin (as Amikacin Sulfate)

Package leaflet: Information for the patient AMIKIN INJECTION 100 mg/2ml Amikacin (as Amikacin Sulfate) Package leaflet: Information for the patient AMIKIN INJECTION 100 mg/2ml Amikacin (as Amikacin Sulfate) Please read all of this leaflet carefully before you start taking your medicine because it contains

More information

BNF CHAPTER 1: GASTROINTESTINAL

BNF CHAPTER 1: GASTROINTESTINAL BNF CHAPTER 1: GASTROINTESTINAL 1.1 DYSPEPSIA AND GASTRO-OESOPHAGEAL REFLUX DISEASE For symptomatic relief of hyperacidity, peptic ulcers, oesophagitis and acid reflux, liquids usually act faster than

More information

Dornase alfa (Pulmozyme ) for cystic fibrosis. Information for patients Pharmacy

Dornase alfa (Pulmozyme ) for cystic fibrosis. Information for patients Pharmacy Dornase alfa (Pulmozyme ) for cystic fibrosis Information for patients Pharmacy page 2 of 8 This leaflet has been made to give you some more information to help you with your treatment. Please also read

More information

If you need the information on this leaflet in an alternative format, such as large text, or Braille please ring from the UK:

If you need the information on this leaflet in an alternative format, such as large text, or Braille please ring from the UK: Package leaflet: Information for the patient MOVICOL-Half 6.9g sachet, powder for oral solution Read all of this leaflet carefully before you start taking this medicine because it contains important information

More information

Long-Term Care Updates

Long-Term Care Updates Long-Term Care Updates May 2016 By Katee Miller, PharmD Candidate, Mohamed Jalloh, PharmD, & Zara Risoldi Cochrane, PharmD, MS, FASCP Introduction Enteral nutrition (EN) through a tube is the preferred

More information

National Horizon Scanning Centre. Mannitol dry powder for inhalation (Bronchitol) for cystic fibrosis. April 2008

National Horizon Scanning Centre. Mannitol dry powder for inhalation (Bronchitol) for cystic fibrosis. April 2008 Mannitol dry powder for inhalation (Bronchitol) for cystic fibrosis April 2008 This technology summary is based on information available at the time of research and a limited literature search. It is not

More information

Cystic Fibrosis: Progress in Treatment Management. Patrick A. Flume, M.D. Medical University of South Carolina

Cystic Fibrosis: Progress in Treatment Management. Patrick A. Flume, M.D. Medical University of South Carolina Cystic Fibrosis: Progress in Treatment Management Patrick A. Flume, M.D. Medical University of South Carolina Disclosures Grant support Mpex Pharmaceuticals, Inc Gilead Sciences, Inc Bayer Healthcare AG

More information

Who should read this document 2 Key points 2 Background/ Scope 2 What is new in this version 2 Policy/Procedure/Guideline 3

Who should read this document 2 Key points 2 Background/ Scope 2 What is new in this version 2 Policy/Procedure/Guideline 3 Nebulised Colistin Colistimethate sodium (Colomycin or Promixin ) for the treatment of Pseudomonas Aeruginosa colonisation and infection in adult patients with non-cf Classification:Shared care protocol

More information

Gastrointestinal system

Gastrointestinal system Gastrointestinal system Medicines Formulary Contents: 1. Dyspepsia and gastro-oesophageal disease 1 2. Acute gastrointestinal bleeding 2 3. Irritable bowel syndrome 3 4. Diarrhoea 3 5. Inflammatory bowel

More information

Hedelix Cough Effervescent Tablets are used to relieve symptoms of chronic inflammatory bronchial conditions; for colds affecting the airways.

Hedelix Cough Effervescent Tablets are used to relieve symptoms of chronic inflammatory bronchial conditions; for colds affecting the airways. Package leaflet: Information for the patient Hedelix Cough Effervescent Tablets 50 mg Active substance: ivy leaf dry extract Read all of this leaflet carefully before you start taking this medicine because

More information

Resuscitation Fluids

Resuscitation Fluids Resuscitation Fluids Acceptable Fluids (also known as): Sodium Chloride Hartmann s Solution (Ringer-Lactate Solution, Compound Sodium Lactate) 4.5% Albumin Solution (PPS) Gelofusine 20ml/kg Bolus Can be

More information

Opinion 24 July COLOBREATHE 1,662,500 IU, inhalation powder, hard capsules B/56, with Turbospin inhaler (CIP: )

Opinion 24 July COLOBREATHE 1,662,500 IU, inhalation powder, hard capsules B/56, with Turbospin inhaler (CIP: ) The legally binding text is the original French version TRANSPARENCY COMMITTEE Opinion 24 July 2013 COLOBREATHE 1,662,500 IU, inhalation powder, hard capsules B/56, with Turbospin inhaler (CIP: 34009 268

More information

Package leaflet: Information for the user. Colobreathe 1,662,500 IU inhalation powder, hard capsules Colistimethate sodium

Package leaflet: Information for the user. Colobreathe 1,662,500 IU inhalation powder, hard capsules Colistimethate sodium Package leaflet: Information for the user Colobreathe 1,662,500 IU inhalation powder, hard capsules Colistimethate sodium Read all of this leaflet carefully before you start using this medicine because

More information

Experience the Powder of Non-nebulized Pa Treatment

Experience the Powder of Non-nebulized Pa Treatment For people 6 years and older with cystic fibrosis (CF), Pseudomonas aeruginosa (Pa), and FEV 1 25% to 80% predicted and who do not have Burkholderia cepacia. Experience the Powder of Non-nebulized Pa Treatment

More information

Medication and Dysphagia To crush or not to crush? Paresh Parmar Care of Elderly & Stroke Pharmacist Northwick Park Hospital

Medication and Dysphagia To crush or not to crush? Paresh Parmar Care of Elderly & Stroke Pharmacist Northwick Park Hospital Medication and Dysphagia To crush or not to crush? Paresh Parmar Care of Elderly & Stroke Pharmacist Northwick Park Hospital 2014 1 OBJECTIVES Role of the pharmacist s understanding of dysphagia To highlight

More information

A NEBULISERS AND NEBULISED MEDICATION. Generic Guide for the use of nebulisers and nebulised medication

A NEBULISERS AND NEBULISED MEDICATION. Generic Guide for the use of nebulisers and nebulised medication A NEBULISERS AND NEBULISED MEDICATION Generic Guide for the use of nebulisers and nebulised medication Aim The aim of this guide is to provide a template for those who wish to develop their own nebuliser

More information

Early Pseudomonas Infection Control (EPIC) Clinical Study. Overview for Families

Early Pseudomonas Infection Control (EPIC) Clinical Study. Overview for Families Early Pseudomonas Infection Control (EPIC) Clinical Study Overview for Families What is the EPIC Clinical Study? The EPIC Clinical Study Compares different treatments for children with CF who have just

More information

This letter is to notify you of recent changes to the PULMOZYME product monograph. Please note, additions/changes have been highlighted in yellow.

This letter is to notify you of recent changes to the PULMOZYME product monograph. Please note, additions/changes have been highlighted in yellow. April 9, 2015 Subject: Revised Product Monograph - PULMOZYME (dornase alfa) Dear Drug Information / Poison Control Centres, This letter is to notify you of recent changes to the PULMOZYME product monograph.

More information

NOVEL INFLUENZA A (H1N1) Swine Flu

NOVEL INFLUENZA A (H1N1) Swine Flu Introduction Definitions Influenza-like Illness Emergency Department Assessment Anitiviral Medication Oseltamivir (Tamiflu) Dosing Infection Control Issues Staff Exposure References Introduction This guideline

More information

Understanding your take home medications from the surgical ward. Information for Patients

Understanding your take home medications from the surgical ward. Information for Patients Understanding your take home medications from the surgical ward Information for Patients i Information for Patients Please read this leaflet before taking the medications that have been prescribed for

More information

Babies 1500g. Caffeine citrate. Sodium Acid Phosphate (1mmol/ml) Ferrous Fumarate (Galfer 140mg/5ml) Infloran. Abidec BMF

Babies 1500g. Caffeine citrate. Sodium Acid Phosphate (1mmol/ml) Ferrous Fumarate (Galfer 140mg/5ml) Infloran. Abidec BMF Babies 1500g Infloran Caffeine citrate BMF Sodium Acid Phosphate (1mmol/ml) Abidec Ferrous Fumarate (Galfer 140mg/5ml) Dose Half capsule BD 10mg/kg once daily (write as caffeine citrate) 2% BMF each feed

More information

Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.

Read all of this leaflet carefully before you start taking this medicine because it contains important information for you. Package leaflet: Information for the patient Hedelix Effervescent Tablets Active substance: ivy leaf dry extract Read all of this leaflet carefully before you start taking this medicine because it contains

More information

Medicines Formulary Blood and electrolyte disorders, and vitamin deficiencies

Medicines Formulary Blood and electrolyte disorders, and vitamin deficiencies Medicines Formulary Blood and electrolyte disorders, and vitamin deficiencies Contents: Blood disorders 1 1. Anaemia 2 A. Non-renal patients 2 B. Patients with chronic kidney disease under the care of

More information

Volume 4; Number 17 November 2010

Volume 4; Number 17 November 2010 Volume 4; Number 17 November 2010 USE OF UNLICENSED PHARMACEUTICAL SPECIALS What are pharmaceutical specials? A pharmaceutical special as defined by law is a medicine made to satisfy an individual patient

More information

Package leaflet: Information for the user. Omnilax 10 g powder for oral solution, sachet. Macrogol 4000

Package leaflet: Information for the user. Omnilax 10 g powder for oral solution, sachet. Macrogol 4000 Package leaflet: Information for the user Omnilax 10 g powder for oral solution, sachet Macrogol 4000 Read all of this leaflet carefully before you start taking this medicine because it contains important

More information

Package leaflet: Information for the user Pulmicort Respules 0.5 mg, Nebuliser Suspension budesonide

Package leaflet: Information for the user Pulmicort Respules 0.5 mg, Nebuliser Suspension budesonide Package leaflet: Information for the user Pulmicort Respules 0.5 mg, Nebuliser Suspension budesonide Read all of this leaflet carefully before you start using this medicine because it contains important

More information

Management of Reflux and GORD

Management of Reflux and GORD Management of Reflux and GORD 1a 2a Title of Guideline (must include the word Guideline (not protocol, policy, procedure etc) Contact Name and Job Title (author) Directorate & Speciality Guideline for

More information

Electrolytes Solution

Electrolytes Solution Electrolytes Solution Substances that are not dissociated in solution are called nonelectrolytes, and those with varying degrees of dissociation are called electrolytes. Urea and dextrose are examples

More information

Orally Nasally Percutaneously Manual, surgical, or endoscopically May be infused into Stomach Duodenum Jejunum

Orally Nasally Percutaneously Manual, surgical, or endoscopically May be infused into Stomach Duodenum Jejunum A Guide to Drug Therapy with Enteral Nutrition. Lamya Alnaim, PharmD Some medications may be given through EN tube Possible problems Tube obstruction Increased toxicity Reduced efficacy In one survey 74%

More information

Pediatric Compounding. Erika Fallon, PharmD/RPh

Pediatric Compounding. Erika Fallon, PharmD/RPh Pediatric Compounding Erika Fallon, PharmD/RPh Disclosure I, Erika Fallon, declare no conflicts of interest, real or apparent, and no financial interests in any company, product, or service mentioned in

More information

PATIENT INFORMATION LEAFLET

PATIENT INFORMATION LEAFLET PATIENT INFORMATION LEAFLET Page 1 of 5 PATIENT INFORMATION LEAFLET: INFORMATION FOR THE USER Capreomycin (as sulfate) 1 g powder for injection * Read all of this leaflet carefully before you start taking

More information

5 Infections. To be used in conjunction with NICE guidance, The British National Formulary for adults and/or children and

5 Infections. To be used in conjunction with NICE guidance, The British National Formulary for adults and/or children and 5 Infections To be used in conjunction with NICE guidance, The British National Formulary for adults and/or children and Southend University Hospital, Antibiotic Guidelines Index 5.1 Antibacterial drugs

More information

5 MUSCULOSKELETAL SYSTEM

5 MUSCULOSKELETAL SYSTEM 5 MUSCULOSKELETAL SYSTEM 5.01 NON-STEROIDAL ANTIILAMMATORY DRUGS (NSAIDS) *Acetylsalicylic Acid (Aspirin) Tab Soluble 300mg Diclofenac Sodium Tab 25mg, Supp 25mg, 50mg & 100mg (Voltaren) 300-900mg every

More information

Quality Use of Medicines in Children

Quality Use of Medicines in Children Welcome to Allied Health Telehealth Quality use of medicines in children To receive an attendance certificate please complete your online evaluation at: https://www.surveymonkey.com/r/qualitymedicines

More information

Clinical Commissioning Policy: Levofloxacin nebuliser solution for chronic Pseudomonas lung infection in cystic fibrosis (all ages)

Clinical Commissioning Policy: Levofloxacin nebuliser solution for chronic Pseudomonas lung infection in cystic fibrosis (all ages) Clinical Commissioning Policy: Levofloxacin nebuliser solution for chronic Pseudomonas lung infection in cystic fibrosis (all ages) NHS England Reference: 1732P NHS England INFORMATION READER BOX Directorate

More information

First steps for managing an outbreak of acute diarrhoea

First steps for managing an outbreak of acute diarrhoea GLOBAL HEALTH SECURITY WORLD HEALTH ORGANIZATION E P I D E M I C A L E R T A N D R E S P O N S E First steps for managing an outbreak of acute diarrhoea THIS LEAFLET AIMS AT GUIDING YOU THROUGH THE VERY

More information

PHYSICIAN SIGNATURE DATE TIME

PHYSICIAN SIGNATURE DATE TIME DRUG AND TREATMENT Condition/Status Patient Status (WCH) Patient Status: Inpatient Update Resident Team C (DEF)* A B X Vital Signs Vital Signs Q4H, Do not wake for vitals 2300-0700 (DEF)* DAILY Q4H Blood

More information

The legally binding text is the original French version TRANSPARENCY COMMITTEE OPINION. 2 June 2010

The legally binding text is the original French version TRANSPARENCY COMMITTEE OPINION. 2 June 2010 The legally binding text is the original French version TRANSPARENCY COMMITTEE OPINION 2 June 2010 COLOKIT, tablets B/32 (CIP: 347 188-1) Applicant: MAYOLY SPINDLER Monosodium phosphate monohydrate Anhydrous

More information

378FM.2 VITAMIN SUPPLEMENTATION FOR PAEDIATRIC CYSTIC FIBROSIS (CF) PATIENTS

378FM.2 VITAMIN SUPPLEMENTATION FOR PAEDIATRIC CYSTIC FIBROSIS (CF) PATIENTS 378FM.2 VITAMIN SUPPLEMENTATION FOR PAEDIATRIC CYSTIC FIBROSIS (CF) PATIENTS Oxford University Hospitals and the Royal Brompton are the tertiary CF centres serving Buckinghamshire. Many patients are under

More information

APPENDIX T - Unit costs of anti-epileptic drugs for 2012 guideline

APPENDIX T - Unit costs of anti-epileptic drugs for 2012 guideline Drug name APPENDIX T - Unit costs of anti-epileptic drugs for 2012 guideline Unit costs and weighted average unit costs for drug used in the treatment of focal and generalised epilepsies Prescription Cost

More information

Guidance on Safe Prescribing of Melatonin for Sleep Disorders in Children, Young People and Adults

Guidance on Safe Prescribing of Melatonin for Sleep Disorders in Children, Young People and Adults Guidance on Safe Prescribing of Melatonin for Sleep Disorders in Children, Young People and Adults Ref: PHARM-0025-v3 Status: FINAL Document type: Guidelines Guidance on Safe Prescribing of Melatonin Page

More information

Priority essential medicines: identifying products. Dr Suzanne Hill September 2010

Priority essential medicines: identifying products. Dr Suzanne Hill September 2010 Priority essential medicines: identifying products Dr Suzanne Hill September 2010 The problem looks like this Robertson, Forte, Trapsida & Hill. Bull WHO 2009 Robertson, Forte, Trapsida & Hill. Bull WHO

More information

Package leaflet: Information for the user. Tobramycin 40 mg/ml Solution for Injection tobramycin

Package leaflet: Information for the user. Tobramycin 40 mg/ml Solution for Injection tobramycin Package leaflet: Information for the user Tobramycin 40 mg/ml Solution for Injection tobramycin Read all of this leaflet carefully before you start using this medicine because it contains important information

More information

PACKAGE LEAFLET. Package leaflet: Information for the user. Vancomycin Hospira 1000 mg Powder for concentrate for solution for infusion.

PACKAGE LEAFLET. Package leaflet: Information for the user. Vancomycin Hospira 1000 mg Powder for concentrate for solution for infusion. PACKAGE LEAFLET Package leaflet: Information for the user Vancomycin Hospira 500 mg Powder for concentrate for solution for infusion Vancomycin Hospira 1000 mg Powder for concentrate for solution for infusion

More information

This leaflet answers some common questions about TOBI Solution for Inhalation ("TOBI").

This leaflet answers some common questions about TOBI Solution for Inhalation (TOBI). TOBI Solution for Inhalation tobramycin Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about TOBI Solution for Inhalation ("TOBI"). It does not contain

More information

New Medicine Assessment

New Medicine Assessment September 2015 New Medicine Assessment Colistimethate sodium/colistin sulfomethate sodium (Colomycin ) Non-Cystic Fibrosis in Patients with Bronchiectasis Colonised with Pseudomonas Aeruginosa Recommendation:

More information